BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 16844458)

  • 1. G-CSF Is a Novel Mediator of T-Cell Suppression and an Immunotherapeutic Target for Women with Colon Cancer.
    Ray AL; Saunders AS; Nofchissey RA; Reidy MA; Kamal M; Lerner MR; Fung KM; Lang ML; Hanson JA; Guo S; Urdaneta-Perez MG; Lewis SE; Cloyde M; Morris KT
    Clin Cancer Res; 2023 Jun; 29(11):2158-2169. PubMed ID: 36951682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors.
    Dwivedi P; Muench DE; Wagner M; Azam M; Grimes HL; Greis KD
    Sci Data; 2019 Apr; 6(1):21. PubMed ID: 30967555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1.
    Zhou M; Niu J; Wang J; Gao H; Shahbaz M; Niu Z; Li Z; Zou X; Liang B
    J Cancer; 2020; 11(13):3803-3815. PubMed ID: 32328185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder Tumors with Multiple Cardiac Metastases, with Elevated Serum Granulocyte Colony-Stimulating Factor.
    Nagasaki N; Watanabe T; Edamura K; Araki M; Sadahira T
    Am J Med; 2023 Aug; 136(8):e161-e162. PubMed ID: 37072095
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of pidotimod combined with azithromycin on children with mycoplasma pneumonia and the expression levels of IL-10 and G-CSF in serum.
    Shi H; Lan L; Lv X; Sun L
    Exp Ther Med; 2019 Sep; 18(3):1800-1806. PubMed ID: 31410140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines.
    Vallo S; Rutz J; Kautsch M; Winkelmann R; Michaelis M; Wezel F; Bartsch G; Haferkamp A; Rothweiler F; Blaheta RA; Cinatl J
    Oncol Lett; 2017 Nov; 14(5):5513-5518. PubMed ID: 29113179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
    Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
    Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact.
    Su Z; Mao YP; OuYang PY; Tang J; Xie FY
    PLoS One; 2015; 10(9):e0136752. PubMed ID: 26336064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
    Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
    PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature.
    Kumar AK; Satyan MT; Holzbeierlein J; Mirza M; Van Veldhuizen P
    J Med Case Rep; 2014 May; 8():147. PubMed ID: 24885603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle.
    Wright CR; Brown EL; Della-Gatta PA; Ward AC; Lynch GS; Russell AP
    Front Physiol; 2014; 5():170. PubMed ID: 24822049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for G-CSF and GM-CSF in nonmyeloid cancers.
    Aliper AM; Frieden-Korovkina VP; Buzdin A; Roumiantsev SA; Zhavoronkov A
    Cancer Med; 2014 Aug; 3(4):737-46. PubMed ID: 24692240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dedifferentiated liposarcoma with leukocytosis. A case report of G-CSF-producing soft-tissue tumors, possible association with undifferentiated liposarcoma lineage.
    Sakamoto A; Matono H; Yoshida T; Tanaka K; Matsuda S; Oda Y; Iwamoto Y
    World J Surg Oncol; 2007 Nov; 5():131. PubMed ID: 18021394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating receptor promotes beta1-integrin-mediated adhesion and invasion of bladder cancer cells.
    Chakraborty A; White SM; Guha S
    Urology; 2006 Jul; 68(1):208-13. PubMed ID: 16844458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
    Chakraborty A; Guha S
    Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer.
    Chakraborty A; White SM; Lerner SP
    Urology; 2004 Jan; 63(1):177-83. PubMed ID: 14751388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK.
    Fusté B; Mazzara R; Escolar G; Merino A; Ordinas A; Díaz-Ricart M
    Haematologica; 2004 May; 89(5):578-85. PubMed ID: 15136221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF production in human bladder cancer and its ability to promote autocrine growth: a review.
    Tachibana M; Murai M
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):113-20. PubMed ID: 9681250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.
    van de Geijn GJ; Aarts LH; Erkeland SJ; Prasher JM; Touw IP
    Rev Physiol Biochem Pharmacol; 2003; 149():53-71. PubMed ID: 12687405
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.